{"query-id": "1", "query-text": "Liposarcoma CDK4 Amplification 38-year-old male GERD", "response": "1. Liposarcoma CDK4 Amplification 45-year-old male hypertension\n2. Liposarcoma CDK4 Amplification 30-year-old female diabetes\n3. Liposarcoma CDK4 Amplification 50-year-old male hyperlipidemia\n4. Liposarcoma CDK4 Amplification 35-year-old female asthma\n5. Liposarcoma CDK4 Amplification 40-year-old male depression", "metadata": {"model": "gpt"}}
{"query-id": "2", "query-text": "Colon cancer KRAS (G13D), BRAF (V600E) 52-year-old male Type II Diabetes, Hypertension", "response": "1. Colon cancer KRAS (G13D), BRAF (V600E) 50-year-old male Type II Diabetes, Hyperlipidemia\n2. Colon cancer KRAS (G13D), BRAF (V600E) 55-year-old male Type II Diabetes, Hypertension, Obesity\n3. Colon cancer KRAS (G13D), BRAF (V600E) 52-year-old female Type II Diabetes, Hypertension\n4. Colon cancer KRAS (G13D), BRAF (V600E) 52-year-old male Type II Diabetes, Hypertension, Smoking history\n5. Colon cancer KRAS (G13D), BRAF (V600E) 53-year-old male Type II Diabetes, Hypertension, Family history of cancer", "metadata": {"model": "gpt"}}
{"query-id": "3", "query-text": "Meningioma NF2 (K322), AKT1(E17K) 45-year-old female None", "response": "1. Meningioma NF2 (K322), AKT1(E17K) 45-year-old female with family history of cancer\n2. Meningioma NF2 (K322), AKT1(E17K) 45-year-old female with previous cancer treatment history\n3. Meningioma NF2 (K322), AKT1(E17K) 45-year-old female with neurological symptoms\n4. Meningioma NF2 (K322), AKT1(E17K) 45-year-old female with comorbid conditions\n5. Meningioma NF2 (K322), AKT1(E17K) 45-year-old female with imaging findings", "metadata": {"model": "gpt"}}
{"query-id": "4", "query-text": "Breast cancer FGFR1 Amplification, PTEN (Q171) 67-year-old female Depression, Hypertension, Heart Disease", "response": "1. Breast cancer FGFR1 Amplification, PTEN (Q171) 67-year-old female Depression, Hypertension, Heart Disease treatment options\n2. Breast cancer FGFR1 Amplification, PTEN (Q171) 67-year-old female Depression, Hypertension, Heart Disease prognosis\n3. Breast cancer FGFR1 Amplification, PTEN (Q171) 67-year-old female Depression, Hypertension, Heart Disease survival rates\n4. Breast cancer FGFR1 Amplification, PTEN (Q171) 67-year-old female Depression, Hypertension, Heart Disease risk factors\n5. Breast cancer FGFR1 Amplification, PTEN (Q171) 67-year-old female Depression, Hypertension, Heart Disease clinical trials", "metadata": {"model": "gpt"}}
{"query-id": "5", "query-text": "Melanoma BRAF (V600E), CDKN2A Deletion 45-year-old female None", "response": "1. Melanoma BRAF (V600E) CDKN2A deletion treatment options\n2. Prognosis of melanoma with BRAF (V600E) and CDKN2A deletion\n3. Melanoma BRAF (V600E) CDKN2A deletion genetic testing\n4. Melanoma BRAF (V600E) CDKN2A deletion survival rates\n5. Melanoma BRAF (V600E) CDKN2A deletion risk factors", "metadata": {"model": "gpt"}}
{"query-id": "6", "query-text": "Melanoma NRAS (Q61K) 55-year-old male Hypertension", "response": "1. Melanoma NRAS mutation in 55-year-old male patients with hypertension\n2. Incidence of NRAS (Q61K) mutation in melanoma patients with hypertension\n3. Treatment options for melanoma patients with NRAS (Q61K) mutation and hypertension\n4. Prognosis of melanoma patients with NRAS (Q61K) mutation who also have hypertension\n5. Risk factors associated with melanoma development in 55-year-old males with NRAS (Q61K) mutation and hypertension", "metadata": {"model": "gpt"}}
{"query-id": "7", "query-text": "Lung cancer EGFR (L858R) 50-year-old female Lupus", "response": "1. Lung cancer EGFR (L858R) treatment options for a 50-year-old female with Lupus\n2. Prognosis of lung cancer with EGFR (L858R) mutation in a 50-year-old female with Lupus\n3. Impact of Lupus on treatment outcomes for lung cancer patients with EGFR (L858R) mutation\n4. Survival rates for 50-year-old female lung cancer patients with EGFR (L858R) mutation and Lupus\n5. Risk factors for developing lung cancer with EGFR (L858R) mutation in a 50-year-old female with Lupus", "metadata": {"model": "gpt"}}
{"query-id": "8", "query-text": "Lung cancer EML4-ALK Fusion transcript 52-year-old male Hypertension, Osteoarthritis", "response": "1. Lung cancer EML4-ALK Fusion transcript 50-year-old male Hypertension, Rheumatoid Arthritis\n2. Lung cancer EML4-ALK Fusion transcript 55-year-old male Hypertension, Diabetes\n3. Lung cancer EML4-ALK Fusion transcript 52-year-old female Hypertension, Osteoporosis\n4. Lung cancer EML4-ALK Fusion transcript 52-year-old male Hypertension, Asthma\n5. Lung cancer EML4-ALK Fusion transcript 52-year-old male Hypertension, Coronary Artery Disease", "metadata": {"model": "gpt"}}
{"query-id": "9", "query-text": "Gastrointestinal stromal tumor KIT Exon 9 (A502_Y503dup) 49-year-old female None", "response": "1. Gastrointestinal stromal tumor KIT Exon 11 (V560D) 55-year-old male None\n2. Gastrointestinal stromal tumor KIT Exon 17 (D816V) 60-year-old female None\n3. Gastrointestinal stromal tumor PDGFRA Exon 18 (D842V) 45-year-old male None\n4. Gastrointestinal stromal tumor KIT Exon 13 (V654A) 52-year-old female None\n5. Gastrointestinal stromal tumor PDGFRA Exon 12 (N566K) 48-year-old male None", "metadata": {"model": "gpt"}}
{"query-id": "10", "query-text": "Lung adenocarcinoma KRAS (G12C) 61-year-old female Hypertension, Hypercholesterolemia", "response": "1. Lung adenocarcinoma KRAS mutation treatment options\n2. Lung adenocarcinoma KRAS (G12C) prognosis\n3. Lung adenocarcinoma KRAS (G12C) targeted therapy\n4. Lung adenocarcinoma KRAS (G12C) clinical trials\n5. Lung adenocarcinoma KRAS (G12C) risk factors", "metadata": {"model": "gpt"}}
{"query-id": "11", "query-text": "Gastric cancer PIK3CA (E545K) 54-year-old male Depression", "response": "1. Gastric cancer PIK3CA mutation treatment options 54-year-old male\n2. Gastric cancer PIK3CA mutation prognosis 54-year-old male\n3. Gastric cancer PIK3CA mutation survival rates 54-year-old male\n4. Gastric cancer PIK3CA mutation clinical trials 54-year-old male\n5. Gastric cancer PIK3CA mutation genetic testing recommendations 54-year-old male", "metadata": {"model": "gpt"}}
{"query-id": "12", "query-text": "Colon cancer BRAF (V600E) 35-year-old male None", "response": "1. Colon cancer BRAF V600E prognosis 35-year-old male None\n2. Treatment options for colon cancer BRAF V600E in 35-year-old male\n3. Genetic testing recommendations for 35-year-old male with colon cancer BRAF V600E\n4. Survival rates for 35-year-old male with colon cancer BRAF V600E\n5. Clinical trials for colon cancer BRAF V600E in 35-year-old male", "metadata": {"model": "gpt"}}
{"query-id": "13", "query-text": "Cholangiocarcinoma BRCA2 72-year-old male Diabetes", "response": "1. Cholangiocarcinoma BRCA2 70-year-old male Hypertension\n2. Cholangiocarcinoma BRCA2 75-year-old male Obesity\n3. Cholangiocarcinoma BRCA2 68-year-old male Family history of cancer\n4. Cholangiocarcinoma BRCA2 73-year-old male Smoker\n5. Cholangiocarcinoma BRCA2 71-year-old male Liver cirrhosis", "metadata": {"model": "gpt"}}
{"query-id": "14", "query-text": "Cholangiocarcinoma IDH1 (R132H) 64-year-old male Neuropathy", "response": "1. Cholangiocarcinoma IDH1 (R132H) prognosis in 64-year-old male patients\n2. Treatment options for cholangiocarcinoma IDH1 (R132H) in patients with neuropathy\n3. Incidence of IDH1 (R132H) mutation in cholangiocarcinoma patients with neuropathy\n4. Survival rates for 64-year-old male patients with cholangiocarcinoma and IDH1 (R132H) mutation\n5. Impact of neuropathy on the progression of cholangiocarcinoma in patients with IDH1 (R132H) mutation", "metadata": {"model": "gpt"}}
{"query-id": "15", "query-text": "Cervical cancer STK11 26-year-old female None", "response": "1. Cervical cancer STK11 30-year-old female None\n2. Cervical cancer STK11 mutation 25-year-old female None\n3. Cervical cancer STK11 gene 27-year-old female None\n4. Cervical cancer STK11 26-year-old woman None\n5. Cervical cancer STK11 mutation 28-year-old female None", "metadata": {"model": "gpt"}}
{"query-id": "16", "query-text": "Pancreatic cancer CDKN2A 54-year-old male Diabetes, Hypertension", "response": "1. Pancreatic cancer CDKN2A 54-year-old male Smoking history\n2. Pancreatic cancer CDKN2A 54-year-old male Family history of cancer\n3. Pancreatic cancer CDKN2A 54-year-old male Chemotherapy treatment\n4. Pancreatic cancer CDKN2A 54-year-old male Weight loss symptoms\n5. Pancreatic cancer CDKN2A 54-year-old male Surgical options for treatment", "metadata": {"model": "gpt"}}
{"query-id": "17", "query-text": "Prostate cancer PTEN Inactivating 81-year-old male Hypertension, Depression", "response": "1. Prostate cancer PTEN mutation 80-year-old male Hypertension, Depression\n2. Prostate cancer PTEN loss 82-year-old male Hypertension, Depression\n3. Prostate cancer PTEN deficiency 79-year-old male Hypertension, Depression\n4. Prostate cancer PTEN alteration 83-year-old male Hypertension, Depression\n5. Prostate cancer PTEN inactivation 84-year-old male Hypertension, Depression", "metadata": {"model": "gpt"}}
{"query-id": "18", "query-text": "Pancreatic cancer CDK6 Amplification 48-year-old male None", "response": "1. Pancreatic cancer CDK6 Amplification 48-year-old male No chemotherapy\n2. Pancreatic cancer CDK6 Amplification 48-year-old male No family history\n3. Pancreatic cancer CDK6 Amplification 48-year-old male No prior surgeries\n4. Pancreatic cancer CDK6 Amplification 48-year-old male No radiation therapy\n5. Pancreatic cancer CDK6 Amplification 48-year-old male No targeted therapy", "metadata": {"model": "gpt"}}
{"query-id": "19", "query-text": "Colorectal cancer FGFR1 Amplification 35-year-old female None", "response": "1. Colorectal cancer FGFR1 mutation 35-year-old female None\n2. Colorectal cancer FGFR1 overexpression 35-year-old female None\n3. Colorectal cancer FGFR1 gene expression 35-year-old female None\n4. Colorectal cancer FGFR1 copy number variation 35-year-old female None\n5. Colorectal cancer FGFR1 protein levels 35-year-old female None", "metadata": {"model": "gpt"}}
{"query-id": "20", "query-text": "Liposarcoma MDM2 Amplification 26-year-old male None", "response": "1. Liposarcoma MDM2 Amplification 30-year-old male None\n2. Liposarcoma MDM2 Amplification 25-year-old male None\n3. Liposarcoma MDM2 Amplification 26-year-old female None\n4. Liposarcoma MDM2 Amplification 26-year-old male Chemotherapy\n5. Liposarcoma MDM2 Amplification 26-year-old male Radiation therapy", "metadata": {"model": "gpt"}}
{"query-id": "21", "query-text": "Lung adenocarcinoma ALK Fusion 64-year-old female Emphysema", "response": "1. Lung adenocarcinoma ALK Fusion 60-year-old male COPD\n2. Lung adenocarcinoma ALK Fusion 65-year-old female Chronic Bronchitis\n3. Lung adenocarcinoma ALK Fusion 60-year-old male Smoker\n4. Lung adenocarcinoma ALK Fusion 65-year-old female Pulmonary Fibrosis\n5. Lung adenocarcinoma ALK Fusion 60-year-old male Asthma", "metadata": {"model": "gpt"}}
{"query-id": "22", "query-text": "Lung cancer ERBB2 Amplification 70-year-old male Arthritis", "response": "1. Lung cancer ERBB2 Amplification treatment options 70-year-old male\n2. Lung cancer ERBB2 Amplification prognosis 70-year-old male\n3. Lung cancer ERBB2 Amplification survival rates 70-year-old male\n4. Lung cancer ERBB2 Amplification targeted therapy 70-year-old male\n5. Lung cancer ERBB2 Amplification clinical trials 70-year-old male", "metadata": {"model": "gpt"}}
{"query-id": "23", "query-text": "Breast cancer PTEN Loss 54-year-old female Congestive Heart Failure", "response": "1. Breast cancer PTEN Loss 54-year-old female Hypertension\n2. Breast cancer PTEN Loss 54-year-old female Diabetes\n3. Breast cancer PTEN Loss 54-year-old female Coronary Artery Disease\n4. Breast cancer PTEN Loss 54-year-old female Stroke\n5. Breast cancer PTEN Loss 54-year-old female Myocardial Infarction", "metadata": {"model": "gpt"}}
{"query-id": "24", "query-text": "Lung cancer NTRK1 58-year-old female Depression, Hypertension, Diabetes", "response": "1. Lung cancer NTRK1 60-year-old female Anxiety, High cholesterol, Arthritis\n2. Lung cancer NTRK1 55-year-old female Bipolar disorder, Asthma, Obesity\n3. Lung cancer NTRK1 65-year-old female PTSD, Thyroid disorder, Osteoporosis\n4. Lung cancer NTRK1 50-year-old female Schizophrenia, COPD, Heart disease\n5. Lung cancer NTRK1 70-year-old female OCD, Stroke, Kidney disease", "metadata": {"model": "gpt"}}
{"query-id": "25", "query-text": "Lung adenocarcinoma MET Amplification 48-year-old male Emphysema", "response": "1. Lung adenocarcinoma MET Amplification 50-year-old male COPD\n2. Lung adenocarcinoma MET Amplification 45-year-old male Chronic bronchitis\n3. Lung adenocarcinoma MET Amplification 47-year-old male Pulmonary fibrosis\n4. Lung adenocarcinoma MET Amplification 49-year-old male Asthma\n5. Lung adenocarcinoma MET Amplification 46-year-old male Chronic obstructive pulmonary disease", "metadata": {"model": "gpt"}}
{"query-id": "26", "query-text": "Breast cancer NRAS Amplification 35-year-old female None", "response": "1. Breast cancer NRAS Amplification 40-year-old female None\n2. Breast cancer NRAS Amplification 35-year-old female Hormone therapy\n3. Breast cancer NRAS Amplification 35-year-old female Chemotherapy\n4. Breast cancer NRAS Amplification 35-year-old female Radiation therapy\n5. Breast cancer NRAS Amplification 35-year-old female Targeted therapy", "metadata": {"model": "gpt"}}
{"query-id": "27", "query-text": "Pancreatic adenocarcinoma KRAS, TP53 49-year-old female None", "response": "1. Pancreatic adenocarcinoma KRAS, TP53 mutations 50-year-old female No comorbidities\n2. Pancreatic ductal adenocarcinoma KRAS, TP53 48-year-old woman No significant medical history\n3. Pancreatic cancer with KRAS and TP53 alterations 49-year-old female No other health conditions\n4. Pancreatic adenocarcinoma with KRAS and TP53 mutations 49-year-old woman No known medical issues\n5. Pancreatic ductal carcinoma KRAS, TP53 50-year-old female No history of chronic illnesses", "metadata": {"model": "gpt"}}
{"query-id": "28", "query-text": "Pancreatic ductal adenocarcinoma ERBB3 73-year-old female Whipple, FNA", "response": "1. Pancreatic ductal adenocarcinoma ERBB3 70-year-old male Whipple, FNA\n2. Pancreatic ductal adenocarcinoma ERBB3 75-year-old female Whipple, FNA\n3. Pancreatic ductal adenocarcinoma ERBB3 73-year-old female Whipple, biopsy\n4. Pancreatic ductal adenocarcinoma ERBB3 73-year-old female Whipple, surgery\n5. Pancreatic ductal adenocarcinoma ERBB3 73-year-old female Whipple, treatment", "metadata": {"model": "gpt"}}
{"query-id": "29", "query-text": "Ampullary carcinoma KRAS 61-year-old male None", "response": "1. Ampullary carcinoma KRAS mutation 61-year-old male No comorbidities\n2. Ampullary cancer KRAS mutation 61-year-old male No significant medical history\n3. Ampullary carcinoma with KRAS mutation 61-year-old male No other health issues\n4. Ampullary tumor KRAS mutation 61-year-old male No known medical conditions\n5. Ampullary adenocarcinoma KRAS mutation 61-year-old male No past medical history", "metadata": {"model": "gpt"}}
{"query-id": "30", "query-text": "Pancreatic adenocarcinoma RB1, TP53, KRAS 57-year-old female None", "response": "1. Pancreatic adenocarcinoma RB1, TP53, KRAS 60-year-old female None\n2. Pancreatic adenocarcinoma RB1, TP53, KRAS 55-year-old female None\n3. Pancreatic adenocarcinoma RB1, TP53, KRAS 57-year-old male None\n4. Pancreatic adenocarcinoma RB1, TP53, KRAS 57-year-old female Chemotherapy\n5. Pancreatic adenocarcinoma RB1, TP53, KRAS 57-year-old female Radiation therapy", "metadata": {"model": "gpt"}}
